Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
about
Second consensus statement on the diagnosis of multiple system atrophyThe utility of neuroimaging in the differential diagnosis of parkinsonian syndromesDiagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutationsCardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism.123I-MIBG cardiac scintigraphy provides clues to the underlying neurodegenerative disorder in idiopathic REM sleep behavior disorderSingle photon-emission computed tomography imaging in early Parkinson's disease.Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.Diagnostic performance of myocardial innervation imaging using MIBG scintigraphy in differential diagnosis between dementia with lewy bodies and other dementias: a systematic review and a meta-analysis.Biomarkers in dementia with Lewy bodies: a review.MIBG scintigraphy in differential diagnosis of Parkinsonism: a meta-analysis.Positron emission tomography in the differential diagnosis of parkinsonism.(123)I-Metaiodobenzylguanidine Myocardial Scintigraphy in Lewy Body-Related Disorders: A Literature Review.Imaging synucleinopathies.The Severity and Pattern of Autonomic Dysfunction in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.Diagnostic and Pathophysiological Impact of Myocardial MIBG Scintigraphy in Parkinson's Disease.Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease.Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases.Cardiac sympathetic denervation in Parkinson's disease patients with SWEDDs.Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations.Low myocardial MIBG uptake in multiple system atrophy with incidental Lewy body pathology: an autopsy case report.The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and 123 I-metaiodobenzylguanidine myocardial scintigraphy for the diagnosis of dementia with LewyNormal 'heart' in Parkinson's disease: is this a distinct clinical phenotype?[Helpful instrumental examinations in idiopathic Parkinson's disease].Comparison of parameters of (123)I-metaiodobenzylguanidine scintigraphy for differential diagnosis in patients with parkinsonism: correlation with clinical features.Potential diagnostic value of regional myocardial adrenergic imaging using (123)I-MIBG SPECT to identify patients with Lewy body diseases.Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson's disease?[Differential diagnostics of Parkinson's disease with nuclear medicine procedures].Role of Neuroimaging as a Biomarker for Neurodegenerative Diseases.The Utility of the Combined Use of 123I-FP-CIT and 123I-MIBG Myocardial Scintigraphy in Differentiating Parkinson’s Disease from Other Parkinsonian Syndromes.
P2860
Q24650965-057D4B7B-DA18-452B-A68E-45E9DA79B76FQ27025731-6C5B5FF7-B46D-4793-AFEC-602CA4AC9E85Q34683979-BCFBDAA8-2AFD-46E2-84FC-3CC6439B575EQ35004642-528F0D68-9BEA-4F6A-A61F-6E9BA8475AE2Q36143071-D9EDC803-45B3-43BC-8006-B8C6E605C70BQ36681412-A628C193-879A-402E-B746-74AE3C857CFAQ37352055-A544EC0C-80CD-4636-AA54-CED4791CE488Q37809870-9055984E-775B-4AA2-B470-54092333438EQ37811053-1D03D098-5940-4697-BF20-7AEDF9727BC0Q37896548-673B3156-C3DF-4E77-BB4C-41BFB89B9018Q37906394-DDE063A5-61E9-4177-A0D0-1BA404734BEFQ38215508-B4213D2E-D24B-4495-83D6-822D6EA72148Q38531996-38B74E3A-6CE0-4283-A26D-C1B121BFEA6AQ38734660-EA5F6D1A-84A0-4EB6-ABC1-743CF9BDE5C3Q40528402-387418BA-5169-4995-AF6B-B98B23701E36Q42408447-25B5AB1A-A60D-48E1-8FEB-9E9E3A9C97A6Q43173986-85521D2F-89CF-4E47-A522-62A95099CAB4Q43982303-6009533C-9390-4E00-B0DA-A2EF423A33A2Q44753131-BD511DB9-685D-4713-B873-290CAB35B714Q46521682-25D3CFF9-C9E4-4028-98E4-602B51D96A72Q46655842-DBB82E7F-342D-4C23-B4F4-E35554DD9CE5Q47769902-0DCA8E66-156B-4B17-A057-3FAB759F64C2Q47790326-6979BD66-F4DD-4D72-AC2A-E8C3B791852BQ50240382-3D7D3A65-EFB4-4136-91D8-E899CBC27BBAQ50264725-0B34A6D0-9EE1-413A-8F41-463FB35EA3C3Q50755449-6FB43CDE-8A3C-4CC3-8912-9A7E9AD8E34EQ51192358-082E27BC-6139-41F2-8C83-5386897041D2Q53066302-BFD8639C-53FE-4F04-BD9E-DDA3D979C83DQ55344088-1083B6D7-957F-4D8E-87EA-88AEA2BDCC5AQ55344774-A6A9CD39-1390-4201-825D-32B01A591EF7
P2860
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@ast
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@en
type
label
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@ast
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@en
prefLabel
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@ast
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@en
P2093
P356
P1476
Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease.
@en
P2093
P304
P356
10.1136/JNNP.2004.037028
P407
P577
2005-02-01T00:00:00Z